Tags: Oxycodone View |
Tags: Oxycodone View |
Oxycodone 15 mg MAL green round Tags: Oxycodone View |
|||||||||
Oxycontin prescription drug side effects pic 1 Oxycontin prescription drug side effects pic 2 Oxycontin prescription drug side effects pic 3 Oxycontin prescription drug side effects OxyContin Information pic 4 Tags: Oxycodone View |
__183477_T.jpg "Oxycontin prescription drug side effects pic 1 Oxycontin prescription drug side effects pic 2 Oxycontin prescription drug side effects pic 3 Oxycontin prescription drug side effects OxyContin Information pic 4")
Oxycodone is an opioid analgesic medication synthesized from opium-derived thebaine. It was developed in 1916 in Germany, as one of several new semi-synthetic opioids in an attempt to improve on the existing opiates and opioids: morphine, diacetylmorphine (heroin), and codeine.
Oxycodone oral medications are generally prescribed for the relief of moderate to severe pain. Currently it is formulated as single ingredient products or compounded products. Some common examples of compounding are oxycodone with acetaminophen or NSAIDs such as ibuprofen. The formulations are available as generics but are also made under various brand names.
OxyContin is Purdue Pharmas brand for time-release single-ingredient oxycodone oral medication. The manufacturing rights to generic oxycodone time-release are under dispute.
Watchedfields: changed
Verifiedrevid: 267473871
Iupac Name: (5''R'',9''R'',13''S'',14''S'')-4,5?-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
Image2: Oxycodone_balls_3d.png
Number on List: 76-42-6
Casno Ref: cascite
Synonyms: dihydrohydroxycodeinone, 14-hydroxydihydrocodeinone, 6-deoxy-7,8-dihydro-14-hydroxy-3-O-methyl-6-oxomorphine
Chemspiderid: 4447649
Atc Prefix: N02
Atc Suffix: AA05
Atc Supplemental: ATCN02AA55 (in combinations)
Pubchem: 5284603
Drugbank: DB00497
C: 18 H=21 N=1 O=4
Molecular Weight: 315.364 g/mol
Smiles: COc1ccc2CC@@H3N(C)CCC@@45C@@H(Oc1c24)C(=O)CCC@@35O
Bioavailability: Up to 87%
Protein Bound: 45%
Metabolism: Hepatic (CYP450: 2D6 substrate)
Elimination Half-life: 3 - 4.5 hr
Pregnancy Category: B/D (prolonged use or in high doses at term)
Legal Au: Schedule 8
Legal Ca: Schedule I
Legal Uk: Class A (CD)
Legal Us: Schedule II
Routes Of Administration: oral, intramuscular, intravenous, intranasal, subcutaneous, transdermal, rectal, epidural
Dependency Liability: Moderate - High
Excretion: Urine (19% unchanged)